|
Found 12 result(s) FROM 1963 pages containing the term 'advertising'.
Wednesday Apr 08, 2009
FDA Warns Pharma on "Sponsored Links"
FDA has warned 14 pharmaceutical companies about the brief ads that accompany internet search results...
Monday Jan 12, 2009
Do FDA Statin Ad Rules Make Patients Fear Myopathy?
Statins cause no more muscle problems than placebo, so why do so many patients (and some physicians) worry?...
Thursday Sep 18, 2008
Consumer Ads for Medical Devices Subject of Senate Panel
A Senate committee is holding a hearing on consumer-directed promotions of medical devices such as artificial knees and heart stents after reports have claimed such promotions can mislead patients and influence them to have unnecessary surgeries…
Monday Jan 14, 2008
Drug Approved. Is Disease Real?
As Pfizer markets Lyrica® (pregabalin), the first approved medicine to treat fibromyalgia, doctors debate the legitimacy of the pain syndrome...
Tuesday Apr 17, 2007
Is the "Golden Moment of Opportunity" to Improve FDA's Drug Safety Work About to Be Wasted?
The FDA's proposals for the reauthorization of the Prescription Drug User Fee Act are weighed and found wanting by experts in three New England Journal of Medicine commentaries...
Wednesday Jan 18, 2006
P&G and Sanofi-Aventis File Lawsuit Against Roche and GSK Alleging False and Misleading Advertising for Osteoporosis Drug Boniva®
Procter & Gamble Pharmaceuticals and Sanofi-Aventis US, LLC, co-marketers of Actonel® (risedronate sodium) tablets, announced that they have filed...
Tuesday Nov 29, 2005
Leading Rheumatologists Sound Off on Limitations of GAIT Study
The initial results of the $14 million National Institutes of Health Glucosamine/Chondroitin Arthritis Intervention Trial failed to show any real benefit for patients with mild-to-moderate knee osteoarthritis, leaving many rheumatologists in a quandary about what they should tell patients regarding the use of these readily available supplements... Clegg DO, et al. Annual Meeting of the American College of Rheumatology; November 12–17, 2005; San Diego, Calif. Abstract 622.
Monday Sep 19, 2005
A Leading Rheumatologist Reflects on How Cyclooxygenase Became a Household Word
Just as it appeared that the dust from the great COX-2 controversies had begun to settle, a jury in Texas awarded a plaintiff a judgment against Merck & Co for one quarter of a billion dollars - indeed, for a death that, arguably, was not Vioxx-related.
Tuesday Apr 12, 2005
New Lupus Public Service Campaign Seeks to Raise Awareness and Speed Diagnosis
The Lupus Research Institute and other organizations hope the new campaign will alert patients to the often vague signs and symptoms of lupus earlier in the course of the disease...Lupus Research Institute [press release]. April 6, 2005.
Monday Feb 28, 2005
New Minimally Invasive Knee Arthroplasty Techniques Present Promise, Challenges
Direct-to-consumer marketing has spurred patient demand for minimally invasive joint replacements, but widespread application of these procedures is limited by a lack of experienced surgeons and of data supporting their use... The 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons; February 23-27, 2005; Washington, DC.
Friday Feb 18, 2005
FDA Advisory Panel Votes to Keep Pfizer COX-2 Inhibitors Celecoxib and Valdecoxib on the Market
An FDA advisory panel concluded today that while safety concerns clearly exist with celecoxib and valdecoxib, their overall benefits outweigh potential CV risks... US FDA Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee; February 18, 2005.
Tuesday Dec 21, 2004
Cancer-Prevention Trial Reveals Elevated Cardiovascular Risk Associated With Celebrex
National Cancer Institute study results, which showed a heightened cardiovascular risk versus placebo among patients taking the COX-2 inhibitor celecoxib at up to 4 times higher than recommended doses, runs counter to recent evidence that the agent may have cardioprotective properties in some arthritis patients... Kimmel SE, et al. Ann Intern Med. 2005;142(3).
|
